Surface Oncology, Inc. Annual Operating Income (Loss) in USD from 2016 to 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Surface Oncology, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2022.
  • Surface Oncology, Inc. Operating Income (Loss) for the quarter ending June 30, 2023 was -$25.6M, a 4.13% decline year-over-year.
  • Surface Oncology, Inc. Operating Income (Loss) for the twelve months ending June 30, 2023 was -$89.4M, a 47.4% decline year-over-year.
  • Surface Oncology, Inc. annual Operating Income (Loss) for 2022 was -$61.9M, a 18.6% increase from 2021.
  • Surface Oncology, Inc. annual Operating Income (Loss) for 2021 was -$76M, a 223% decline from 2020.
  • Surface Oncology, Inc. annual Operating Income (Loss) for 2020 was $61.6M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$61.9M +$14.1M +18.6% Jan 1, 2022 Dec 31, 2022 8-K 2023-07-03
2021 -$76M -$138M -223% Jan 1, 2021 Dec 31, 2021 8-K 2023-07-03
2020 $61.6M +$119M Jan 1, 2020 Dec 31, 2020 8-K 2023-07-03
2019 -$57.4M -$48.2M -527% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-02
2018 -$9.15M +$36.8M +80.1% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-09
2017 -$46M -$28M -155% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-10
2016 -$18M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.